Route of administration matters because peptides face two chemical obstacles: degradation before they reach the target, and inability to cross biological barriers
Published research summaries and references can be accessed via public scientific databases such as PubMed
Typical research dosing ranges : Loading phase : 410 mg per week, divided into 23 doses, for 46 weeks
CagriSema: Two Molecules, Complementary Mechanisms CagriSema combines two existing molecules in a fixed-dose injection
How CG1 Is Supplied Each CG1 vial is supplied as lyophilised powder with no excipients, preservatives or diluent included
Even for partial tears, proper rehabilitation is essential alongside any peptide protocol, and imaging follow-up helps determine whether conservative management is working